343 related articles for article (PubMed ID: 37197632)
1. Significance of circulating tumor cells in lung cancer: a narrative review.
Hamilton G; Rath B; Stickler S
Transl Lung Cancer Res; 2023 Apr; 12(4):877-894. PubMed ID: 37197632
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
Hamilton G; Rath B
Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
[TBL] [Abstract][Full Text] [Related]
3. Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation.
Rath B; Plangger A; Klameth L; Hochmair M; Ulsperger E; Boeckx B; Neumayer C; Hamilton G
Explor Target Antitumor Ther; 2023; 4(2):355-365. PubMed ID: 37205313
[TBL] [Abstract][Full Text] [Related]
4. Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells.
Stickler S; Rath B; Hochmair M; Lang C; Weigl L; Hamilton G
Oncol Res; 2023; 31(1):13-22. PubMed ID: 37303738
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal detection of subcategorized CD44v6
Wang Y; Zhang L; Tan J; Zhang Z; Liu Y; Hu X; Lu B; Gao Y; Tong L; Liu Z; Zhang H; Lin PP; Li B; Gires O; Zhang T
Cancer Lett; 2023 Sep; 571():216337. PubMed ID: 37553013
[TBL] [Abstract][Full Text] [Related]
6. Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
Hochmair M; Rath B; Klameth L; Ulsperger E; Weinlinger C; Fazekas A; Plangger A; Zeillinger R; Hamilton G
Invest New Drugs; 2020 Aug; 38(4):946-955. PubMed ID: 31446534
[TBL] [Abstract][Full Text] [Related]
7. Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines.
Rath B; Klameth L; Plangger A; Hochmair M; Ulsperger E; Huk I; Zeillinger R; Hamilton G
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669448
[TBL] [Abstract][Full Text] [Related]
8. Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance.
Klameth L; Rath B; Hochmaier M; Moser D; Redl M; Mungenast F; Gelles K; Ulsperger E; Zeillinger R; Hamilton G
Sci Rep; 2017 Jul; 7(1):5337. PubMed ID: 28706293
[TBL] [Abstract][Full Text] [Related]
9. Role of circulating tumor cell spheroids in drug resistance.
Hamilton G; Rath B
Cancer Drug Resist; 2019; 2(3):762-772. PubMed ID: 35582592
[TBL] [Abstract][Full Text] [Related]
10. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cell interactions with macrophages: implications for biology and treatment.
Hamilton G; Rath B
Transl Lung Cancer Res; 2017 Aug; 6(4):418-430. PubMed ID: 28904886
[TBL] [Abstract][Full Text] [Related]
13. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis.
Zhu HH; Liu YT; Feng Y; Zhang LN; Zhang TM; Dong GL; Xing PY; Wang HY; Shi YK; Hu XS
Thorac Cancer; 2021 Oct; 12(20):2749-2757. PubMed ID: 34423906
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease.
Hanssen A; Riebensahm C; Mohme M; Joosse SA; Velthaus JL; Berger LA; Bernreuther C; Glatzel M; Loges S; Lamszus K; Westphal M; Riethdorf S; Pantel K; Wikman H
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30572662
[TBL] [Abstract][Full Text] [Related]
18. Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cells.
Hamilton G; Rath B; Holzer S; Hochmair M
Transl Lung Cancer Res; 2016 Feb; 5(1):71-7. PubMed ID: 26958494
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.
Shishido SN; Carlsson A; Nieva J; Bethel K; Hicks JB; Bazhenova L; Kuhn P
J Transl Med; 2019 Aug; 17(1):294. PubMed ID: 31462312
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway.
Liao ZJ; Guo YH; Zhao Z; Yao JT; Xu R; Nan KJ
Int J Oncol; 2014 Aug; 45(2):651-8. PubMed ID: 24867356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
